291
Participants
Start Date
November 29, 2022
Primary Completion Date
January 19, 2027
Study Completion Date
November 7, 2028
SAR445877
Concentrate for solution for infusion
Cetuximab
Solution for infusion
RECRUITING
START MADRID_Hospital Universitario HM Sanchinarro - CIOCC_Investigational Site Number : 7240005, Madrid
RECRUITING
University of Iowa- Site Number : 8400014, Iowa City
RECRUITING
Investigational Site Number : 3760001, Tel Aviv
RECRUITING
Investigational Site Number : 3760004, Be’er Ya‘aqov
RECRUITING
Hadassah Medical Center - PPDS_Investigational Site Number : 3760005, Jerusalem
RECRUITING
Investigational Site Number : 1520002, Rancagua
RECRUITING
Sheba Medical Center - PPDS_Investigational Site Number : 3760003, Ramat Gan
RECRUITING
Investigational Site Number : 1520007, Providencia
RECRUITING
Investigational Site Number : 1520008, Santiago
RECRUITING
Investigational Site Number : 1520004, Recoleta
RECRUITING
Christiana Care Health System- Site Number : 8400011, Newark
RECRUITING
University of Kansas Cancer Center Clinical Research Center (Fairway) Site Number : 8400008, Fairway
RECRUITING
Barbara Ann Karmanos Cancer Institute- Site Number : 8400006, Detroit
RECRUITING
John Theurer Cancer Center Site Number : 8400001, Hackensack
RECRUITING
NYU Langone Medical Center-New York- 550 1st Ave - BRANY - PPDS- Site Number : 8400013, New York
RECRUITING
Rhode Island Hospital Site Number : 8400004, Providence
RECRUITING
University of Texas MD Anderson Cancer Center Site Number : 8400005, Houston
RECRUITING
Fred Hutchinson Cancer Center - 825 Eastlake Ave E- Site Number : 8400010, Seattle
RECRUITING
Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis_Investigational Site Number : 5280001, Amsterdam
RECRUITING
Erasmus MC_Investigational Site Number : 5280003, Rotterdam
RECRUITING
Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON_Investigational Site Number : 7240007, Barcelona
Lead Sponsor
Sanofi
INDUSTRY